• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人体测量指标与欧洲癌症与营养前瞻性调查中的上皮性卵巢癌风险

Anthropometric measures and epithelial ovarian cancer risk in the European Prospective Investigation into Cancer and Nutrition.

机构信息

Department of Epidemiology, German Institute of Human Nutrition Potsdam-Rehbrücke, Nuthetal, Germany.

出版信息

Int J Cancer. 2010 May 15;126(10):2404-15. doi: 10.1002/ijc.24952.

DOI:10.1002/ijc.24952
PMID:19821492
Abstract

We examined the associations of measured anthropometric factors, including general and central adiposity and height, with ovarian cancer risk. We also investigated these associations by menopausal status and for specific histological subtypes. Among 226,798 women in the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort, there were 611 incident cases of primary, malignant, epithelial ovarian cancer diagnosed during a mean 8.9 years of follow-up. Cox proportional hazards models were used to estimate hazard ratios (HRs) and 95% confidence intervals (CIs), adjusted for potential confounders. Compared to women with body mass index (BMI) < 25 kg/m2, obesity (BMI > or = 30 kg/m2) was associated with excess ovarian cancer risk for all women combined (HR = 1.33, 95% CI = 1.05-1.68; p(trend) = 0.02) and postmenopausal women (HR = 1.59, 95% CI = 1.20-2.10; p(trend) = 0.001), but the association was weaker for premenopausal women (HR = 1.16, 95% CI = 0.65-2.06; p(trend) = 0.65). Neither height or weight gain, nor BMI-adjusted measures of fat distribution assessed by waist circumference, waist-hip ratio (WHR) or hip circumference were associated with overall risk. WHR was related to increased risk of mucinous tumors (BMI-adjusted HR per 0.05 unit increment = 1.17, 95% CI = 1.00-1.38). For all women combined, no other significant associations with risk were observed for specific histological subtypes. This large, prospective study provides evidence that obesity is an important modifiable risk factor for epithelial ovarian cancer, particularly among postmenopausal women.

摘要

我们研究了包括一般和中心性肥胖以及身高在内的测量人体测量学因素与卵巢癌风险之间的关联。我们还根据绝经状态和特定的组织学亚型研究了这些关联。在欧洲癌症与营养前瞻性调查(EPIC)队列中,有 226798 名女性,平均随访 8.9 年后,诊断出 611 例原发性、恶性、上皮性卵巢癌。使用 Cox 比例风险模型估计风险比(HR)和 95%置信区间(CI),并调整了潜在混杂因素。与 BMI<25kg/m2 的女性相比,所有女性的肥胖症(BMI≥30kg/m2)与卵巢癌风险增加相关(HR=1.33,95%CI=1.05-1.68;p(trend)=0.02),绝经后女性(HR=1.59,95%CI=1.20-2.10;p(trend)=0.001),但对于绝经前女性,这种相关性较弱(HR=1.16,95%CI=0.65-2.06;p(trend)=0.65)。身高或体重增加,或通过腰围、腰臀比(WHR)或臀围评估的 BMI 调整后脂肪分布的测量值均与总体风险无关。WHR 与黏液性肿瘤的风险增加相关(每增加 0.05 个单位的 BMI 调整 HR=1.17,95%CI=1.00-1.38)。对于所有女性,未观察到与特定组织学亚型相关的其他显著风险关联。这项大型前瞻性研究提供了证据表明肥胖是上皮性卵巢癌的一个重要可改变风险因素,特别是在绝经后女性中。

相似文献

1
Anthropometric measures and epithelial ovarian cancer risk in the European Prospective Investigation into Cancer and Nutrition.人体测量指标与欧洲癌症与营养前瞻性调查中的上皮性卵巢癌风险
Int J Cancer. 2010 May 15;126(10):2404-15. doi: 10.1002/ijc.24952.
2
Body size and risk of colon and rectal cancer in the European Prospective Investigation Into Cancer and Nutrition (EPIC).欧洲癌症与营养前瞻性调查(EPIC)中身体大小与结肠癌和直肠癌风险的关系
J Natl Cancer Inst. 2006 Jul 5;98(13):920-31. doi: 10.1093/jnci/djj246.
3
Anthropometric measures and risk of epithelial ovarian cancer: results from the nurses' health study.人体测量学指标与上皮性卵巢癌风险:护士健康研究的结果。
Obesity (Silver Spring). 2010 Aug;18(8):1625-31. doi: 10.1038/oby.2009.461. Epub 2009 Dec 24.
4
Comparison of abdominal adiposity and overall obesity in relation to risk of small intestinal cancer in a European Prospective Cohort.欧洲前瞻性队列研究中腹部肥胖和总体肥胖与小肠癌风险的比较
Cancer Causes Control. 2016 Jul;27(7):919-27. doi: 10.1007/s10552-016-0772-z. Epub 2016 Jun 13.
5
Anthropometric measures and epithelial ovarian cancer risk among Chinese women: results from the Shanghai Women's Health Study.中国人的人体测量指标与上皮性卵巢癌风险:上海女性健康研究结果。
Br J Cancer. 2013 Aug 6;109(3):751-5. doi: 10.1038/bjc.2013.384. Epub 2013 Jul 16.
6
Self-reported and measured anthropometric data and risk of colorectal cancer in the EPIC-Norfolk study.EPIC-Norfolk 研究中自我报告和测量的人体测量学数据与结直肠癌风险。
Int J Obes (Lond). 2012 Jan;36(1):107-18. doi: 10.1038/ijo.2011.61. Epub 2011 Mar 22.
7
Pre-diagnostic anthropometry and survival after colorectal cancer diagnosis in Western European populations.西欧人群结直肠癌诊断前人体测量学与诊断后的生存情况
Int J Cancer. 2014 Oct 15;135(8):1949-60. doi: 10.1002/ijc.28841. Epub 2014 Apr 7.
8
Anthropometric factors and risk of endometrial cancer: the European prospective investigation into cancer and nutrition.人体测量因素与子宫内膜癌风险:欧洲癌症与营养前瞻性调查
Cancer Causes Control. 2007 May;18(4):399-413. doi: 10.1007/s10552-006-0113-8. Epub 2007 Feb 12.
9
Central and peripheral adiposity and premenopausal breast cancer risk: a pooled analysis of 440,179 women.中心性和外周性肥胖与绝经前乳腺癌风险:440179名女性的汇总分析
Breast Cancer Res. 2025 Apr 15;27(1):55. doi: 10.1186/s13058-025-01995-x.
10
Body size and breast cancer risk: findings from the European Prospective Investigation into Cancer And Nutrition (EPIC).体型与乳腺癌风险:欧洲癌症与营养前瞻性调查(EPIC)的研究结果
Int J Cancer. 2004 Sep 20;111(5):762-71. doi: 10.1002/ijc.20315.

引用本文的文献

1
Unveiling the causal link between metabolic factors and ovarian cancer risk using Mendelian randomization analysis.采用孟德尔随机化分析揭示代谢因素与卵巢癌风险之间的因果关联。
Front Endocrinol (Lausanne). 2024 Jun 5;15:1401648. doi: 10.3389/fendo.2024.1401648. eCollection 2024.
2
Obesity modulates the cellular and molecular microenvironment in the peritoneal cavity: implication for ovarian cancer risk.肥胖会调节腹腔内的细胞和分子微环境:对卵巢癌风险的影响。
Front Immunol. 2024 Jan 9;14:1323399. doi: 10.3389/fimmu.2023.1323399. eCollection 2023.
3
FABP4 in obesity-associated carcinogenesis: Novel insights into mechanisms and therapeutic implications.
脂肪酸结合蛋白4在肥胖相关致癌作用中的研究:对机制及治疗意义的新见解
Front Mol Biosci. 2022 Aug 19;9:973955. doi: 10.3389/fmolb.2022.973955. eCollection 2022.
4
Anthropometric risk factors for ovarian cancer in the NIH-AARP Diet and Health Study.美国国立卫生研究院-美国退休人员协会饮食与健康研究中的卵巢癌人体测量危险因素。
Cancer Causes Control. 2021 Mar;32(3):231-239. doi: 10.1007/s10552-020-01377-y. Epub 2021 Jan 22.
5
Mendelian randomisation study of height and body mass index as modifiers of ovarian cancer risk in 22,588 BRCA1 and BRCA2 mutation carriers.孟德尔随机化研究身高和体重指数作为 22588 名 BRCA1 和 BRCA2 基因突变携带者卵巢癌风险的修饰因素。
Br J Cancer. 2019 Jul;121(2):180-192. doi: 10.1038/s41416-019-0492-8. Epub 2019 Jun 19.
6
Increased efficacy of metformin corresponds to differential metabolic effects in the ovarian tumors from obese lean mice.二甲双胍疗效的提高与肥胖和瘦小鼠卵巢肿瘤中不同的代谢效应相对应。
Oncotarget. 2017 Sep 8;8(67):110965-110982. doi: 10.18632/oncotarget.20754. eCollection 2017 Dec 19.
7
Anthropometric characteristics and ovarian cancer risk and survival.人体测量学特征与卵巢癌风险及生存情况
Cancer Causes Control. 2018 Feb;29(2):201-212. doi: 10.1007/s10552-017-0997-5. Epub 2018 Jan 11.
8
Phenformin has anti-tumorigenic effects in human ovarian cancer cells and in an orthotopic mouse model of serous ovarian cancer.苯乙双胍在人卵巢癌细胞和浆液性卵巢癌原位小鼠模型中具有抗肿瘤作用。
Oncotarget. 2017 Oct 24;8(59):100113-100127. doi: 10.18632/oncotarget.22012. eCollection 2017 Nov 21.
9
Cancer incidence attributable to excess body weight in Alberta in 2012.2012年艾伯塔省因超重导致的癌症发病率。
CMAJ Open. 2017 Apr 28;5(2):E330-E336. doi: 10.9778/cmajo.20160039.
10
Epidemiology of ovarian cancer: a review.卵巢癌流行病学综述
Cancer Biol Med. 2017 Feb;14(1):9-32. doi: 10.20892/j.issn.2095-3941.2016.0084.